NRG-GY009

A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer

For more information about this clinical trial, click here

Schema & Eligibility NRG-GY009

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO

Ask your physician about participating in this clinical trial or call us.